Lower expression of KAI1 as a biomarker of poor survival prognosis of melanoma combined with colorectal cancer metastasis.

Du, Xudong; Wang, Bo; Liu, Lei; Li, Yang; Wang, Zheng-Xiang; Zhang, Guang-Jing; Yang, Xiu-Fang

Du, Xudong; Wang, Bo; Liu, Lei; Li, Yang; Wang, Zheng-Xiang; Zhang, Guang-Jing; Yang, Xiu-Fang.

Affiliation

Du X; Department of Gastrointestinal Surgery, Xi'an No. 3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, Shanxi, P.R. China.
Wang B; Department of Gastrointestinal Surgery, Xi'an No. 3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, Shanxi, P.R. China.
Liu L; Department of Pediatrics, Xi'an No. 3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, Shanxi, P.R. China.
Li Y; Department of Obstetrics and Gynecology, Xi'an No. 3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, Shanxi, P.R. China.
Wang ZX; Department of Dermatology, Cangzhou Central Hospital, No. 16 Xinhua Western Road, Cangzhou, Hebei, P.R. China.
Zhang GJ; Department of Dermatology, Cangzhou Central Hospital, No. 16 Xinhua Western Road, Cangzhou, Hebei, P.R. China.
Yang XF; Department of Dermatology, Cangzhou Central Hospital, No. 16 Xinhua Western Road, Cangzhou, Hebei, P.R. China.

J Int Med Res ; 50(8): 3000605221116758, 2022 Aug.

Article de En | MEDLINE | ID: mdl-35942551

Sujet(s)
Mots clés

KAI1; Melanoma; colorectal cancer; miR-633; prognosis; survival time

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs colorectales / MicroARN / Antigène CD82 / Mélanome Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: J Int Med Res Année: 2022 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google